Sun Pharma Q4 net profit at Rs 635.88 cr
Drug major Sun Pharmaceutical Industries Tuesday reported a consolidated net profit of Rs 635.88 crore for the fourth quarter ended on March 31, 2019.
The company had posted a net profit of Rs 1,342.50 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.
The profit was mainly impacted by distribution change for its India business.
The company said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of distribution change for India business in the fourth quarter of 2018-19 as well as the one-time tax benefit of Rs 259 crore for the same quarter during the last year.
Earlier in April this year, Sun Pharma had said that the transition of distribution related to India domestic formulations business from Aditya Medisales to company's arm Sun Pharma Distributors will impact the financial results for the period ended March 31, 2019.
Consolidated revenue from ...